Tislelizumab,Sorafenib
BeiGene,Novartis,Bayer
[]
tislelizumab provides qol benefit over sorafenib in unresectable hcc #hpbcsm #gi23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.